These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26058662)

  • 1. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
    Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM
    Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
    Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
    ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
    Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
    Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
    Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
    J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opioid receptor binding in major depression: A pilot study.
    Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
    Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
    Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
    Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
    Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
    Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
    Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
    J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets.
    Wang Z; Ma N; Riley J; Armstead WM; Liu R
    PLoS One; 2012; 7(7):e41724. PubMed ID: 22911847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeys.
    Zamarripa CA; Huskinson SL; Townsend EA; Prisinzano TE; Blough BE; Rowlett JK; Freeman KB
    Psychopharmacology (Berl); 2024 Feb; 241(2):305-314. PubMed ID: 37870564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
    Zamarripa CA; Naylor JE; Huskinson SL; Townsend EA; Prisinzano TE; Freeman KB
    Psychopharmacology (Berl); 2020 May; 237(5):1471-1480. PubMed ID: 32006048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats.
    Xin J; Zhang Y; He Z; Wang Z
    Brain Res; 2016 Apr; 1637():168-176. PubMed ID: 26907190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical syntheses of the salvinorin chemotype of KOR agonist.
    Hill SJ; Brion AUCM; Shenvi RA
    Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.
    Polepally PR; Huben K; Vardy E; Setola V; Mosier PD; Roth BL; Zjawiony JK
    Eur J Med Chem; 2014 Oct; 85():818-29. PubMed ID: 25193297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
    Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
    J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
    Potter DN; Damez-Werno D; Carlezon WA; Cohen BM; Chartoff EH
    Biol Psychiatry; 2011 Oct; 70(8):744-753. PubMed ID: 21757186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.